Characterization of Ph-negative abnormal clones emerging during imatinib therapy (Q58449075)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Characterization of Ph-negative abnormal clones emerging during imatinib therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alessandro Gozzetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alessandro Mauriello

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Paolo de Fabritiis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Sara Galimberti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Malgorzata Monika Trawinska

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tommaso Caravita

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Agostina Siniscalchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Giulia Cervetti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Angela Maria Coletta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

2466-2472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Trial of IFN or STI571 before proceeding to allografting for CML?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

STI-571 in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Chromosomal abnormalities in Ph- cells of patients on imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: two case reports

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

The occurrence of Philadelphia chromosome (Ph) negative leukemia after hematopoietic stem cell transplantation for Ph positive chronic myeloid leukemia: implications for disease monitoring and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Ph-positive and -negative myeloproliferative syndromes may co-exist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Inhibitory effect of imatinib on normal progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Growth Characteristics of Myelodysplastic CD34+Cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Angiogenesis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22699

7 January 2021

Identifiers

DOI

10.1002/CNCR.22699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17503437%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference